Open Beta
TREN
MetriLume
TREN

US marketsCOCH

SEC-sourced researchBeta

COCH

Envoy Medical, Inc.

Company comparison ↗

Data passport

CIK
0001840877
Exchange
Nasdaq
Business activity
— · SIC 3842
Financial inputs
6/6
Filing date
Sep 14, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 225,000.0000 USD; December 2025: 241,000.0000 USD241K USD0 USD0December 2024December 2025
COCH · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2024225,000.0000Mar 23, 2026
December 2025241,000.0000Mar 23, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025241,000.0000-23,756,000.0000-18,201,000.00008,558,000.000020,325,000.0000Mar 23, 2026
December 2024225,000.0000-20,795,000.0000-17,949,000.000011,538,000.000030,380,000.0000Mar 23, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$241KDecember 2025Mar 23, 202610-K
Previous period revenueRevenues$225KDecember 2024Mar 23, 202610-K
Net incomeNetIncomeLoss-$23.76MDecember 2025Mar 23, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$18.2MDecember 2025Mar 23, 202610-K
Total assetsAssets$8.56MDecember 2025Mar 23, 202610-K
Total liabilitiesLiabilities$20.33MDecember 2025Mar 23, 202610-K

New filings

Explore methodology ↗